WO2001053520A3 - Genchip für ein neugeborenen screening - Google Patents

Genchip für ein neugeborenen screening Download PDF

Info

Publication number
WO2001053520A3
WO2001053520A3 PCT/EP2001/000139 EP0100139W WO0153520A3 WO 2001053520 A3 WO2001053520 A3 WO 2001053520A3 EP 0100139 W EP0100139 W EP 0100139W WO 0153520 A3 WO0153520 A3 WO 0153520A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene chip
neonate
screening
neonate screening
sequences
Prior art date
Application number
PCT/EP2001/000139
Other languages
English (en)
French (fr)
Other versions
WO2001053520A2 (de
Inventor
Paul Cullen
Udo Seedorf
Original Assignee
Paul Cullen
Udo Seedorf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Cullen, Udo Seedorf filed Critical Paul Cullen
Priority to EP01907415A priority Critical patent/EP1301622A2/de
Priority to JP2001553380A priority patent/JP2004500076A/ja
Priority to CA002398058A priority patent/CA2398058A1/en
Priority to AU2001235400A priority patent/AU2001235400A1/en
Publication of WO2001053520A2 publication Critical patent/WO2001053520A2/de
Publication of WO2001053520A3 publication Critical patent/WO2001053520A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Nukleotidträger mit einer Auswahl von Oligonukleotidsequenzen für den Nachweis von für mindestens zwei Phänotypen relevanten Referenzsequenzen, bzw. deren funktionell charakterisierten Mutationen, wobei die Oligonukleotidsequenzen identisch oder komplementär zu den Referenzsequenzen sind.
PCT/EP2001/000139 2000-01-21 2001-01-09 Genchip für ein neugeborenen screening WO2001053520A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01907415A EP1301622A2 (de) 2000-01-21 2001-01-09 Genchip für ein neugeborenen screening
JP2001553380A JP2004500076A (ja) 2000-01-21 2001-01-09 新生児スクリーニングのためのジーンチップ
CA002398058A CA2398058A1 (en) 2000-01-21 2001-01-09 Gene chip for neonate screening
AU2001235400A AU2001235400A1 (en) 2000-01-21 2001-01-09 Gene chip for neonate screening

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10002446.7 2000-01-21
DE10002446A DE10002446A1 (de) 2000-01-21 2000-01-21 Genchip für ein Neugeborenen Screening

Publications (2)

Publication Number Publication Date
WO2001053520A2 WO2001053520A2 (de) 2001-07-26
WO2001053520A3 true WO2001053520A3 (de) 2003-01-23

Family

ID=7628226

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/000139 WO2001053520A2 (de) 2000-01-21 2001-01-09 Genchip für ein neugeborenen screening

Country Status (6)

Country Link
EP (1) EP1301622A2 (de)
JP (1) JP2004500076A (de)
AU (1) AU2001235400A1 (de)
CA (1) CA2398058A1 (de)
DE (1) DE10002446A1 (de)
WO (1) WO2001053520A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
DE10111925A1 (de) * 2001-03-13 2002-10-02 Ogham Gmbh Herzchip
DE10237073A1 (de) * 2002-08-09 2004-02-19 Ogham Gmbh Methode zur Bestimmung eines erblichen Thromboserisikos mit DNA-arrays
FR2880897B1 (fr) * 2005-01-18 2010-12-17 Inst Nat Sante Rech Med Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256630A1 (de) * 1986-07-31 1988-02-24 Howard Hughes Medical Institute Spezifische Sonde zur Identifikation von Mutationen in den humanen Phenylalaningenen
US5750335A (en) * 1992-04-24 1998-05-12 Massachusetts Institute Of Technology Screening for genetic variation
EP0962464A2 (de) * 1996-01-23 1999-12-08 Rapigene, Inc. Methoden und Zusammensetzungen zum Nachweis der Bindung eines Liganden-Paars mittels nicht-fluoriszierender Markierungen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256630A1 (de) * 1986-07-31 1988-02-24 Howard Hughes Medical Institute Spezifische Sonde zur Identifikation von Mutationen in den humanen Phenylalaningenen
US5750335A (en) * 1992-04-24 1998-05-12 Massachusetts Institute Of Technology Screening for genetic variation
EP0962464A2 (de) * 1996-01-23 1999-12-08 Rapigene, Inc. Methoden und Zusammensetzungen zum Nachweis der Bindung eines Liganden-Paars mittels nicht-fluoriszierender Markierungen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CRONIN M T ET AL: "CYSTIC FIBROSIS MUTATION DETECTION BY HYBRIDIZATION TO LIGHT-GENERATED DNA PROBE ARRAYS", HUMAN MUTATION, WILEY-LISS, NEW YORK, NY, US, vol. 7, 1996, pages 244 - 255, XP000991050, ISSN: 1059-7794 *
EIKEN H G ET AL: "APPLICATION OF NATURAL AND AMPLIFICATION CREATED RESTRICTION SITES FOR THE DIAGNOSIS OF PKU MUTATIONS", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 19, no. 7, 11 April 1991 (1991-04-11), pages 1427 - 1430, XP000371877, ISSN: 0305-1048 *
EIKEN HANS GEIR ET AL: "A de novo phenylketonuria mutation: ATG (Met) to ATA (Ile) in the start codon of the phenylalanine hydroxylase gene.", HUMAN MUTATION, vol. 1, no. 5, 1992, pages 388 - 391, XP001073536, ISSN: 1059-7794 *

Also Published As

Publication number Publication date
CA2398058A1 (en) 2001-07-26
WO2001053520A2 (de) 2001-07-26
DE10002446A1 (de) 2001-08-16
EP1301622A2 (de) 2003-04-16
AU2001235400A1 (en) 2001-07-31
JP2004500076A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
WO2002002809A3 (en) Diagnosis of behavioural disorders, neurological disorders and cancer
HUP0004115A2 (en) Novel nucleotide sequences coding for the pck gene
WO2001077378A3 (en) Diagnosis of diseases associated with dna adducts
WO2002018641A3 (en) Detection of cyp3a4 and cyp2c9 polymorphisms
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
HUP0104068A3 (en) Nucleotide sequences which code for the opca gene
ZA200007270B (en) Novel Nucleotide sequences coding for the zwa2 gene.
AU2003254597A8 (en) Dna chip based genetic typing
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ZA200005409B (en) New nucleotide sequences which code for the eno gene.
WO2002046454A3 (de) Diagnose von mit angiogenese assoziierten krankheiten durch bestimmung der methylierung von mit angiogenese assoziierten genen
WO2001053520A3 (de) Genchip für ein neugeborenen screening
WO2002036814A3 (de) Diagnose von mit cdk4 assoziierten krankheiten durch bestimmung des methylierungszustandes des cdk4
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ZA200309754B (en) Nucleotide sequences involved in disease resistance.
AU2002345437A1 (en) Nucleotide sequences involved in plant disease resistance
AU2001278509A1 (en) Nucleotide sequences which code for the atr43 gene
WO2002006487A3 (de) Regulatorische sequenzen aus meristematischen zellen
MXPA01010381A (es) Metodos para determinar polimorfismos de acidos nucleicos sencillos utilizando un microchip bioelectronico.
AU2001293808A1 (en) Nucleotide sequences which code for the atr61 gene
AU2001291658A1 (en) Nucleotide sequences which code for the ccpa2 gene
AU2002212255A1 (en) Nucleotide sequences which code for the trub gene
AU2001293730A1 (en) Nucleotide sequences which code for the chra gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2398058

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 553380

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001907415

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001235400

Country of ref document: AU

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001907415

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001907415

Country of ref document: EP